Amifostine
Advance Directives, prophylaxis of renal toxicity, Xerostomia + 4 more
Treatment
7 FDA approvals
1 Active Study for Amifostine
Treatment for
Advance Directives
What is Amifostine
Amifostine
The Generic name of this drug
Treatment Summary
A phosphorothioate is a type of drug that is proposed to protect people from radiation. It works by causing the spleen to widen and blocking the autonomic ganglia, which are nerve pathways that control many automatic body functions.
Ethyol
is the brand name
Amifostine Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Ethyol
Amifostine
1995
6
Approved as Treatment by the FDA
Amifostine, also known as Ethyol, is approved by the FDA for 7 uses like prophylaxis of renal toxicity and Advance Directives .
prophylaxis of renal toxicity
Advance Directives
prophylaxis of Xerostomia
Malignant Neoplasms
Nephrotoxicity
Xerostomia
Xerostomia
Effectiveness
How Amifostine Affects Patients
Amifostine is a drug used to help protect the kidneys from the side effects of chemotherapy medication and to reduce the risk of dry mouth in those undergoing radiation therapy for head and neck cancer. It works by being converted into an active form that can better protect healthy cells from damage caused by these treatments. It also concentrates more in healthy cells than in cancer cells, providing further protection.
How Amifostine works in the body
Amifostine has protective properties that help cells. It is taken up by cells to bind to and block chemicals that are toxic or cause harm. It also works to reduce the amount of free radicals in cells, as well as stop cell death and change gene expression.
When to interrupt dosage
The amount of Amifostine is contingent upon the diagnosed situation, including Nephrotoxicity, Dry Mouth and Proctitis. The dosage also deviates depending on the technique of delivery documented in the table below.
Condition
Dosage
Administration
Advance Directives
50.0 mg/mL, , 500.0 mg
, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for solution - Intravenous, Powder, for solution
Malignant Neoplasms
50.0 mg/mL, , 500.0 mg
, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for solution - Intravenous, Powder, for solution
Nephrotoxicity
50.0 mg/mL, , 500.0 mg
, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for solution - Intravenous, Powder, for solution
Xerostomia
50.0 mg/mL, , 500.0 mg
, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for solution - Intravenous, Powder, for solution
prophylaxis of renal toxicity
50.0 mg/mL, , 500.0 mg
, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for solution - Intravenous, Powder, for solution
Xerostomia
50.0 mg/mL, , 500.0 mg
, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for solution - Intravenous, Powder, for solution
Proctitis
50.0 mg/mL, , 500.0 mg
, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for solution - Intravenous, Powder, for solution
Warnings
There are 20 known major drug interactions with Amifostine.
Common Amifostine Drug Interactions
Drug Name
Risk Level
Description
Amyl Nitrite
Minor
The risk or severity of adverse effects can be increased when Amifostine is combined with Amyl Nitrite.
Arotinolol
Minor
The risk or severity of adverse effects can be increased when Amifostine is combined with Arotinolol.
Arsenic trioxide
Minor
The risk or severity of adverse effects can be increased when Amifostine is combined with Arsenic trioxide.
Barnidipine
Minor
The risk or severity of adverse effects can be increased when Amifostine is combined with Barnidipine.
Bromocriptine
Minor
The risk or severity of adverse effects can be increased when Amifostine is combined with Bromocriptine.
Amifostine Toxicity & Overdose Risk
The lowest toxic dose of this drug in rats is 826mg/kg.
Amifostine Novel Uses: Which Conditions Have a Clinical Trial Featuring Amifostine?
Two ongoing studies are assessing the potential of Amifostine to reduce symptoms of Malignant Neoplasms, Dry Mouth and mitigate renal toxicity prophylaxis.
Condition
Clinical Trials
Trial Phases
prophylaxis of renal toxicity
0 Actively Recruiting
Advance Directives
0 Actively Recruiting
Malignant Neoplasms
0 Actively Recruiting
Xerostomia
0 Actively Recruiting
Proctitis
0 Actively Recruiting
Nephrotoxicity
1 Actively Recruiting
Phase 3
Xerostomia
0 Actively Recruiting
Amifostine Reviews: What are patients saying about Amifostine?
1.7
Patient Review
1/7/2008
Amifostine for Prevent Decreased White Blood Cell Count from Cancer Chemotherapy
Patient Q&A Section about amifostine
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
When do you give amifostine?
"Amifostine is injected into a vein before radiation or chemotherapy starts. Blood pressure is monitored frequently during the treatment. Patients may be asked to drink more fluids than usual for 24 hours before the infusion."
Answered by AI
What is amifostine used for?
"Amifostine is given to patients receiving cisplatin chemotherapy for ovarian cancer to prevent kidney damage, and to those undergoing radiation therapy for head and neck cancer to decrease mouth dryness."
Answered by AI
What class of drug is Amifostine?
"Organophosphates are a class of chemicals that contain phosphorus. Many organophosphates are used as pesticides or oil additives, while some have medical applications. The general chemical formula for an organophosphate is (RO)₃PS, [(RO)₂PO]⁻, R(RO)₂PS, etc."
Answered by AI
Is amifostine still used?
"Amifostine was approved by the FDA for reducing xerostomia in patients receiving postoperative head and neck radiation therapy, and it is still the only radiation protector that is FDA approved for clinical use."
Answered by AI